Dmitrii V Kalinin/LinkedIn
Nov 6, 2026, 22:15
Dmitrii Kalinin: Allosteric Anticoagulation – An Alternative Strategy for Safer, Next-Generation Anticoagulants
Dmitrii Kalinin, Lecturer and Assistant Professor at the University of Galway, shared a post on LinkedIn about his recent article, published in Expert Opinion on Therapeutic Patents, adding:
“Some thoughts on allosteric anticoagulation, an alternative strategy in the search for safer, next-generation anticoagulants.”
Title: Allosteric anticoagulation: emerging non-orthosteric inhibitors of factor XI and factor XIa
Authors: Dmitrii Kalinin
Stay updaed on all scientific advances with Hemostasis Today.
-
Nov 7, 2026, 15:34Salih Ehsan: Iron Deficiency Beyond Conventional Ferritin Cutoffs
-
Nov 7, 2026, 15:21Shamee Shastry: Improving the Reliability and Reproducibility of the Monocyte Monolayer Assay
-
Nov 7, 2026, 14:39AI-Assisted Donor Screening and Transfusion Decision Support: A Prospective Multicentre Evaluation
-
Nov 7, 2026, 14:26Qiong Tang: Changing Perspectives on Iron Deficiency and Supplementation
-
Nov 7, 2026, 14:21Nathan Connell: Bringing VWD Education Across Borders to Improve Patient Care
-
Nov 7, 2026, 14:02David McIntosh: Thalassaemia Care Needs More Than Breakthrough Therapies
-
Nov 7, 2026, 14:00Farzin Beygui: SOLOTAVI Tests Aspirin Discontinuation After TAVI
-
Nov 7, 2026, 13:50Edward Lee Carter: Is Aspirin Monotherapy Sufficient After Watchman Implantation?
-
Nov 7, 2026, 13:40Leticia Leal: Preventing Blood Clots During Long Flights